Skip to main content
. Author manuscript; available in PMC: 2023 Jan 18.
Published in final edited form as: Biomater Sci. 2022 Jan 18;10(2):444–456. doi: 10.1039/d1bm01539g

Fig. 2.

Fig. 2

Echocardiographic measurements. (A) TAPSE measurements for control, bare patch, and neonatal patch groups across 0–4 weeks of treatment. TAPSE value is normalized to TAPSE at two weeks before patch implantation (immediately before PAB surgery) within rat. * = p-value <0.05, # = no significant difference from Sham group values within week grouping. (B) End-diastolic dimension (EDD) measurements for control, bare patch, and neonatal patch groups at week 4 post-patch implantation. (C) End-systolic dimension (ESD) measurements for control groups, bare patch groups, and neonatal patch groups at week 4 post-patch implantation. (D) Right atrium area (RA-Area) measurements for control groups, bare patch groups, and neonatal patch groups at week 4 post-patch implantation. In figures B, C, and D, * = p-value <0.05. Statistical values are given by ANOVA with Tukey’s post-test, n = 5–7 for all groups at all time-points.